Keep Up With McLean!
Receive the latest news in your inbox each month.
Roger D. Weiss, MD, chief of McLean Hospital’s Center of Excellence in Alcohol, Drugs, and Addiction, has been selected as the 2012 recipient of the Hazelden Foundation’s Dan Anderson Research Award. Sponsored by the Butler Center for Research at Hazelden, the Dan Anderson Research Award recognizes a single published article by a researcher who has advanced the scientific knowledge of addiction recovery.
Weiss was nominated for his work on the study “Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence,” published in the December 2011 issue of Archives of General Psychiatry (PMID: 22065255).
“The Scientific Panel of the Butler Center for Research reviewed many nominations and Dr. Weiss’ work was selected as the best among several excellent candidates,” said Audrey Klein, PhD, director of the Butler Center for Research at Hazelden. “In addition to his fine career, the panel members were especially impressed with the methodological design of his study and the fact that he examined the effects of both short-term and longer-term buprenorphine maintenance on opioid use outcomes.”
McLean Hospital Chief Academic Officer Shelly F. Greenfield, MD, MPH, nominated Weiss for the coveted Anderson Research Award.
“Dr. Weiss is well known for his contributions to the field of addiction psychiatry and his mentorship, clinical consultation, and research expertise are sought locally at McLean Hospital and Harvard Medical School, as well as throughout the country,” Greenfield. “I nominated Roger’s Archives paper for the Dan Anderson Research Award because it had widespread implications for improving treatment outcomes for opioid-dependent patients. This study was the catalyst for changing treatment protocols for this patient population.”
According to Klein, Weiss scored highly on each of the criteria areas used to select the winner, including innovation, applicability of research to treatment, potential impact on the field, rigor of scientific methodology, explication of theory, quality of writing, and overall role model as a researcher. “We are excited to provide Dr. Weiss with this important award in memory of Dr. Dan Anderson, a pioneer in addiction treatment. Dr. Weiss’ work is excellent. He has made, and continues to make, a significant impact in the field,” she added.
The award, which includes a $2,000 honorarium, is named for the late Dan Anderson, PhD, the former president of Hazelden and one of the major architects of the Minnesota Model, the interdisciplinary approach to addiction treatment that has been implemented worldwide.
Back to top